Wendell David Associates Inc. reduced its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,878 shares of the pharmacy operator’s stock after selling 10,250 shares during the period. Wendell David Associates Inc.’s holdings in Walgreens Boots Alliance were worth $5,728,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of WBA. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after acquiring an additional 1,926,108 shares during the period. Franklin Resources Inc. grew its stake in Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after acquiring an additional 3,662,302 shares during the period. Nordea Investment Management AB grew its stake in Walgreens Boots Alliance by 1.0% in the 3rd quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock worth $786,284,000 after acquiring an additional 96,552 shares during the period. Dimensional Fund Advisors LP grew its stake in Walgreens Boots Alliance by 12.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,641,826 shares of the pharmacy operator’s stock worth $512,893,000 after acquiring an additional 735,917 shares during the period. Finally, CI Global Investments Inc. grew its stake in Walgreens Boots Alliance by 4.8% in the 2nd quarter. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator’s stock worth $464,503,000 after acquiring an additional 270,182 shares during the period. Hedge funds and other institutional investors own 61.20% of the company’s stock.
In other news, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Stefano Pessina acquired 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The stock was purchased at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.
Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $76.47 on Friday. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The firm has a market cap of $75,290.84, a price-to-earnings ratio of 14.39, a P/E/G ratio of 1.28 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the prior year, the company earned $1.10 EPS. The firm’s revenue was up 7.9% on a year-over-year basis. analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current year.
Walgreens Boots Alliance declared that its Board of Directors has approved a share repurchase program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.09%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 44.20%.
WBA has been the subject of several recent analyst reports. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research note on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Raymond James Financial reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. Leerink Swann cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 1st. Loop Capital set a $90.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Thursday, October 26th. Finally, SunTrust Banks set a $72.00 target price on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Sunday, October 15th. Nine investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $86.20.
WARNING: This piece was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://ledgergazette.com/2018/01/20/wendell-david-associates-inc-cuts-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.